Literature DB >> 19339985

The utility of tracheal aspirate cultures in the immediate neonatal period.

G R Booth1, M Al-Hosni, A Ali, W J Keenan.   

Abstract

OBJECTIVE: Determine the contemporary incidence of pathogenic tracheal aspirate (TA) cultures when obtained within 12 h of birth, and to associate TA culture results with specific clinical conditions that increase the risk of infection. STUDY
DESIGN: A retrospective study over a 6-month period of admissions to a single outborn neonatal intensive care unit when a TA sample was collected within 12 h of birth (n=139). RESULT: In total, 9 of 139 (6.5%) TA cultures were positive for pathogenic bacterial growth. Maternal fever (relative risk (RR)=7.7, P<0.04) and clinical chorioamnionitis (RR=6.4, P<0.02) were significantly associated with pathogenic TA culture results. Infants with a pathogenic TA culture had lower white blood cell counts (7,500 vs 13,900 mm(-3), P<0.05) when compared with infants with a negative culture. In eight of the nine patients with pathogenic cultures, either the mother or the infant received antibiotics before TA sample collection.
CONCLUSION: Early TA culture is a helpful tool in diagnosing pneumonia, especially in certain clinical scenarios, including maternal fever, clinical chorioamnionitis and leukopenia. Administration of antibiotics before sample collection does not seem to preclude culture growth.

Entities:  

Mesh:

Year:  2009        PMID: 19339985     DOI: 10.1038/jp.2009.33

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  2 in total

1.  Association of Endotracheal Aspirate Culture Variability and Antibiotic Use in Mechanically Ventilated Pediatric Patients.

Authors:  Andrea Prinzi; Sarah K Parker; Cary Thurm; Meghan Birkholz; Anna Sick-Samuels
Journal:  JAMA Netw Open       Date:  2021-12-01

2.  Infection control and other stewardship strategies in late onset sepsis, necrotizing enterocolitis, and localized infection in the neonatal intensive care unit.

Authors:  Samia Aleem; Megan Wohlfarth; C Michael Cotten; Rachel G Greenberg
Journal:  Semin Perinatol       Date:  2020-10-12       Impact factor: 3.300

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.